Duke University Medical Center
Durham, North Carolina, 27713, United States
NCT Number: NCT04320862
Coronavirus Disease 19 (COVID-19) represents an unprecedented challenge to the operations and population health management efforts of health care systems around the world. The "Pandemic Research Network (PRN): Duke Community Health Watch" study leverages technology, clinical research, epidemiology, telemedicine, and population health management capabilities to understand how to safely COVID-19. The target population is individuals in the Duke Health region as well as individuals beyond the Duke Health region who have flu-like symptoms, a viral test order for COVID-19, confirmed COVID-19, or concern for exposure to COVID-19. A subgroup of particular interest within the target population is health care workers (HCW) and families of HCW. Community members will enroll in the study electronically and for 28 days will be reminded via email or SMS to submit signs and symptoms related to COVID-19. Participants who report symptoms will be provided information about COVID-19 testing (if needed) and established mechanisms to seek care within Duke Health. Instructions for telemedicine and in-person visits, which is available publicly at https://www.dukehealth.org/covid-19-update, will be presented to participants. Participants who are unable to report symptoms independently may be contacted via telephone by Population Health Management Office (PHMO) or Clinical Events Classification (CEC) team members. Data collected through the "Pandemic Response Network (PRN): Duke Community Health Watch" study will be used for three objectives.
* First, to characterize the epidemiological features of COVID-19. Specifically, we will have a high-risk subgroup of HCW and families of HCW that we enroll. * Second, to develop models that predict deterioration and the need for inpatient care, intensive care, and mechanical ventilation. * Third, to develop forecast models to estimate the volume of inpatient and outpatient resources needed to manage a COVID-19 population.
The primary risk to study participants is loss of protected health information. To address this concern, all data will be stored in Duke's REDCap instance and the Duke Protected Analytics Compute Environment (PACE).
Looking for future studies?
Notify MeAll sexes
Observational
Durham, North Carolina, 27713, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 months
Time frame: 2 months
Time frame: 2 months
Time frame: 2 months
Duke University
Other
Pandemic Response Network: Duke Community Health Watch
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04362995
COVID-19, Coronaviridae Infections
Memphis, Tennessee, United States
View Trial DetailsNCT04690413
COVID-19, Coronaviridae Infections
Tucson, Arizona, United States
View Trial DetailsNCT04449276
COVID-19, Coronaviridae Infections
Ghent, Belgium
View Trial DetailsNCT04362176
COVID-19, Coronaviridae Infections
Little Rock, Arkansas, United States
View Trial Details